How may the reduction of some cardiovascular diseases affect Brazilian population’s life expectancy?

Detalhes bibliográficos
Autor(a) principal: Araujo,Raphael H. O.
Data de Publicação: 2021
Outros Autores: Barboni,André R., Silva,Danilo R. P., Gomes,Thayse N. Q., Sampaio,Ricardo A. C., Miranda,J. Jaime, Silva,Roberto J. S.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista brasileira de estudos de população (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-30982021000100177
Resumo: Abstract This study aimed to analyze the impact of cardiovascular diseases (CVDs) on life expectancy (LE) in the Brazilian population; and to identify how the hypothetical reduction in mortality from 5 to 30%, as well as the hypothetical scenario with no deaths (i.e., elimination) of these diseases would affect LE. This is a simulation study using national cross-sectional data. To identify the impact of CVDs on LE, we used multiple decrement life table models, considering hypothetical CVDs reductions in mortality from 5 to 30% and their elimination. The estimated overall potential gains in LE [years (%)] from the elimination of ischemic disease, hypertensive disease, and cerebrovascular disease were 1.44y (2%) and 1.31y (1.7%), 0.51y (0.7%) and 0.75y (1%), and 1.28y (1.8%) and 1.62y (2.1%), for males and females, respectively. The largest gains in LE were observed among those who live in Brazil’s Northeast region. For the overall population, the estimated gains in LE linked to a 5% reduction in CVD mortality for males and females were 0.07y (0.1%) and 0.06y (0.08%) for ischemic disease, 0.02y (0.03%) and 0.04y (0.05%) for hypertensive disease, and 0.06y (0.08%) and 0.07y (0.09%) for cerebrovascular disease. A hypothetical decrease of 30% in mortality by CVDs would lead to gains in LE, for males and females, of 0.41y (0.6%) and 0.37y (0.5%) for ischemic disease, 0.15y (0.2%) and 0.22y (0.3%) for hypertensive disease, and 0.36y (0.5%) and 0.45y (0.6%) for cerebrovascular disease. Thus, investment towards improving CVDs, including CVD prevention efforts, would increase LE in Brazil, especially in less developed regions.
id ABEP-1_dc353730bbfe3b34c7e4f0ecf41f2495
oai_identifier_str oai:scielo:S0102-30982021000100177
network_acronym_str ABEP-1
network_name_str Revista brasileira de estudos de população (Online)
repository_id_str
spelling How may the reduction of some cardiovascular diseases affect Brazilian population’s life expectancy?HypertensionCardiovascular diseaseIschemiaLife expectancyLife tablesMortalityPreventionBrazilAbstract This study aimed to analyze the impact of cardiovascular diseases (CVDs) on life expectancy (LE) in the Brazilian population; and to identify how the hypothetical reduction in mortality from 5 to 30%, as well as the hypothetical scenario with no deaths (i.e., elimination) of these diseases would affect LE. This is a simulation study using national cross-sectional data. To identify the impact of CVDs on LE, we used multiple decrement life table models, considering hypothetical CVDs reductions in mortality from 5 to 30% and their elimination. The estimated overall potential gains in LE [years (%)] from the elimination of ischemic disease, hypertensive disease, and cerebrovascular disease were 1.44y (2%) and 1.31y (1.7%), 0.51y (0.7%) and 0.75y (1%), and 1.28y (1.8%) and 1.62y (2.1%), for males and females, respectively. The largest gains in LE were observed among those who live in Brazil’s Northeast region. For the overall population, the estimated gains in LE linked to a 5% reduction in CVD mortality for males and females were 0.07y (0.1%) and 0.06y (0.08%) for ischemic disease, 0.02y (0.03%) and 0.04y (0.05%) for hypertensive disease, and 0.06y (0.08%) and 0.07y (0.09%) for cerebrovascular disease. A hypothetical decrease of 30% in mortality by CVDs would lead to gains in LE, for males and females, of 0.41y (0.6%) and 0.37y (0.5%) for ischemic disease, 0.15y (0.2%) and 0.22y (0.3%) for hypertensive disease, and 0.36y (0.5%) and 0.45y (0.6%) for cerebrovascular disease. Thus, investment towards improving CVDs, including CVD prevention efforts, would increase LE in Brazil, especially in less developed regions.Associação Brasileira de Estudos Populacionais2021-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-30982021000100177Revista Brasileira de Estudos de População v.38 2021reponame:Revista brasileira de estudos de população (Online)instname:Associação Brasileira de Estudos Populacionais (ABEP)instacron:ABEP10.20947/s0102-3098a0174info:eu-repo/semantics/openAccessAraujo,Raphael H. O.Barboni,André R.Silva,Danilo R. P.Gomes,Thayse N. Q.Sampaio,Ricardo A. C.Miranda,J. JaimeSilva,Roberto J. S.eng2021-10-05T00:00:00Zoai:scielo:S0102-30982021000100177Revistahttps://rebep.org.br/revistahttps://old.scielo.br/oai/scielo-oai.php||editora@rebep.org.br1980-55190102-3098opendoar:2021-10-05T00:00Revista brasileira de estudos de população (Online) - Associação Brasileira de Estudos Populacionais (ABEP)false
dc.title.none.fl_str_mv How may the reduction of some cardiovascular diseases affect Brazilian population’s life expectancy?
title How may the reduction of some cardiovascular diseases affect Brazilian population’s life expectancy?
spellingShingle How may the reduction of some cardiovascular diseases affect Brazilian population’s life expectancy?
Araujo,Raphael H. O.
Hypertension
Cardiovascular disease
Ischemia
Life expectancy
Life tables
Mortality
Prevention
Brazil
title_short How may the reduction of some cardiovascular diseases affect Brazilian population’s life expectancy?
title_full How may the reduction of some cardiovascular diseases affect Brazilian population’s life expectancy?
title_fullStr How may the reduction of some cardiovascular diseases affect Brazilian population’s life expectancy?
title_full_unstemmed How may the reduction of some cardiovascular diseases affect Brazilian population’s life expectancy?
title_sort How may the reduction of some cardiovascular diseases affect Brazilian population’s life expectancy?
author Araujo,Raphael H. O.
author_facet Araujo,Raphael H. O.
Barboni,André R.
Silva,Danilo R. P.
Gomes,Thayse N. Q.
Sampaio,Ricardo A. C.
Miranda,J. Jaime
Silva,Roberto J. S.
author_role author
author2 Barboni,André R.
Silva,Danilo R. P.
Gomes,Thayse N. Q.
Sampaio,Ricardo A. C.
Miranda,J. Jaime
Silva,Roberto J. S.
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Araujo,Raphael H. O.
Barboni,André R.
Silva,Danilo R. P.
Gomes,Thayse N. Q.
Sampaio,Ricardo A. C.
Miranda,J. Jaime
Silva,Roberto J. S.
dc.subject.por.fl_str_mv Hypertension
Cardiovascular disease
Ischemia
Life expectancy
Life tables
Mortality
Prevention
Brazil
topic Hypertension
Cardiovascular disease
Ischemia
Life expectancy
Life tables
Mortality
Prevention
Brazil
description Abstract This study aimed to analyze the impact of cardiovascular diseases (CVDs) on life expectancy (LE) in the Brazilian population; and to identify how the hypothetical reduction in mortality from 5 to 30%, as well as the hypothetical scenario with no deaths (i.e., elimination) of these diseases would affect LE. This is a simulation study using national cross-sectional data. To identify the impact of CVDs on LE, we used multiple decrement life table models, considering hypothetical CVDs reductions in mortality from 5 to 30% and their elimination. The estimated overall potential gains in LE [years (%)] from the elimination of ischemic disease, hypertensive disease, and cerebrovascular disease were 1.44y (2%) and 1.31y (1.7%), 0.51y (0.7%) and 0.75y (1%), and 1.28y (1.8%) and 1.62y (2.1%), for males and females, respectively. The largest gains in LE were observed among those who live in Brazil’s Northeast region. For the overall population, the estimated gains in LE linked to a 5% reduction in CVD mortality for males and females were 0.07y (0.1%) and 0.06y (0.08%) for ischemic disease, 0.02y (0.03%) and 0.04y (0.05%) for hypertensive disease, and 0.06y (0.08%) and 0.07y (0.09%) for cerebrovascular disease. A hypothetical decrease of 30% in mortality by CVDs would lead to gains in LE, for males and females, of 0.41y (0.6%) and 0.37y (0.5%) for ischemic disease, 0.15y (0.2%) and 0.22y (0.3%) for hypertensive disease, and 0.36y (0.5%) and 0.45y (0.6%) for cerebrovascular disease. Thus, investment towards improving CVDs, including CVD prevention efforts, would increase LE in Brazil, especially in less developed regions.
publishDate 2021
dc.date.none.fl_str_mv 2021-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-30982021000100177
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-30982021000100177
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.20947/s0102-3098a0174
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Associação Brasileira de Estudos Populacionais
publisher.none.fl_str_mv Associação Brasileira de Estudos Populacionais
dc.source.none.fl_str_mv Revista Brasileira de Estudos de População v.38 2021
reponame:Revista brasileira de estudos de população (Online)
instname:Associação Brasileira de Estudos Populacionais (ABEP)
instacron:ABEP
instname_str Associação Brasileira de Estudos Populacionais (ABEP)
instacron_str ABEP
institution ABEP
reponame_str Revista brasileira de estudos de população (Online)
collection Revista brasileira de estudos de população (Online)
repository.name.fl_str_mv Revista brasileira de estudos de população (Online) - Associação Brasileira de Estudos Populacionais (ABEP)
repository.mail.fl_str_mv ||editora@rebep.org.br
_version_ 1754302037537849344